| Respondent |
|
|
|
| Patient |
132 (88) |
65 (87) |
67 (89) |
| Surrogate |
18 (12) |
10 (13) |
8 (11) |
| Age, median (IQR), y |
61 (52-68) |
60 (23-92) |
62 (20-92) |
| Sex |
|
|
|
| Male |
84 (56) |
36 (48) |
48 (64) |
| Female |
66 (44) |
39 (52) |
27 (36) |
| Race or ethnicitya
|
|
|
|
| American Indian or Alaska Native |
2 (1) |
1 (1) |
1 (1) |
| Asian |
2 (1) |
2 (3) |
0 |
| Black |
19 (13) |
9 (12) |
10 (13) |
| Mixed race or ethnicity |
10 (7) |
8 (11) |
2 (3) |
| White |
|
|
|
| Hispanic |
9 (6) |
1 (1) |
8 (11) |
| Non-Hispanic |
107 (72) |
53 (72) |
54 (72) |
| Educational attainment |
|
|
|
| Less than high school diploma |
11 (7) |
4 (5) |
7 (9) |
| High school diploma or equivalent |
26 (17) |
18 (24) |
8 (11) |
| Some college |
66 (44) |
28 (37) |
38 (51) |
| Undergraduate degree |
26 (17) |
13 (17) |
13 (17) |
| Postcollege education |
21 (14) |
12 (16) |
9 (12) |
| Marital statusa
|
|
|
|
| Single |
52 (35) |
23 (31) |
29 (39) |
| Currently married |
46 (31) |
25 (34) |
21 (28) |
| Divorced or widowed |
51 (34) |
26 (35) |
25 (33) |
| Health status |
|
|
|
| Excellent |
6 (4) |
3 (4) |
3 (4) |
| Very good |
6 (4) |
4 (5) |
2 (3) |
| Good |
24 (16) |
13 (17) |
11 (15) |
| Fair |
50 (33) |
23 (31) |
27 (36) |
| Poor |
64 (43) |
32 (43) |
32 (43) |
| Chronic life-limiting illnesses, No. |
|
|
|
| 0 |
10 (7) |
6 (8) |
4 (5) |
| 1 |
64 (43) |
33 (44) |
31 (41) |
| 2 |
34 (23) |
18 (24) |
16 (21) |
| 3 |
21 (14) |
10 (13) |
11 (15) |
| ≥4 |
21 (14) |
8 (11) |
13 (17) |
| Eligibility criteria (not mutually exclusive) |
|
|
|
| Chronic life-limiting illnesses |
|
|
|
| Cancer with poor prognosis |
25 (17) |
15 (20) |
10 (13) |
| Chronic lung disease |
46 (31) |
20 (27) |
26 (35) |
| Coronary artery disease |
43 (29) |
16 (21) |
27 (36) |
| Congestive heart failure |
52 (35) |
23 (31) |
29 (39) |
| Peripheral vascular disease |
21 (14) |
11 (15) |
10 (13) |
| Chronic kidney disease, moderate-to-severe |
56 (37) |
25 (33) |
31 (41) |
| Chronic liver disease, severe |
25 (17) |
14 (19) |
11 (15) |
| Diabetes with end-organ damage |
21 (14) |
10 (13) |
11 (15) |
| Dementia |
6 (4) |
3 (4) |
3 (4) |
| Age ≥65 y with frailtyb
|
11 (7) |
7 (9) |
4 (5) |
| Age ≥80 y |
9 (6) |
7 (9) |
2 (3) |
